Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Social heterogeneity drives complex patterns of the COVID-19 pandemic: insights from a novel Stochastic Heterogeneous Epidemic Model (SHEM)

View ORCID ProfileAlexander V. Maltsev, View ORCID ProfileMichael D. Stern
doi: https://doi.org/10.1101/2020.07.10.20150813
Alexander V. Maltsev
1Translational Gerontology Branch, National Institute on Aging/NIH, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Alexander V. Maltsev
Michael D. Stern
2Laboratory of Cardiovascular Science, National Institute on Aging/NIH, Baltimore, MD, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Michael D. Stern
  • For correspondence: SternMi@mail.nih.gov
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

In today’s absence of a vaccine and impactful treatments, the most effective way to combat the virus is to find and implement mitigation strategies. An invaluable resource in this task is numerical modeling that can reveal key factors in COVID-19 pandemic development. On the other hand, it has become evident that regional infection curves of COVID-19 exhibit complex patterns which often differ from curves predicted by forecasting models. The wide variations in attack rate observed among different social strata suggest that this may be due to social heterogeneity not accounted for by regional models. We investigated this hypothesis by developing and using a new Stochastic Heterogeneous Epidemic Model (SHEM) that focuses on vulnerable subpopulations. We found that the isolation or embedding of vulnerable sub-clusters in a major population hub generated complex stochastic infection patterns which included multiple peaks and growth periods, an extended plateau, a prolonged tail, or a delayed second wave of infection. Embedded vulnerable groups became hotspots that drove infection despite efforts of the main population to socially distance, while isolated groups suffered delayed but intense infection. Amplification of infection by these hotspots facilitated transmission from one urban area to another, causing the epidemic to hopscotch in a stochastic manner to places it would not otherwise reach, resembling a microcosm of the situation worldwide as of September 2020. Our results suggest that social heterogeneity is a key factor in the formation of complex infection propagation patterns. Thus, the mitigation of vulnerable groups is essential to control the COVID-19 pandemic worldwide. The design of our new model allows it to be applied in future studies of real-world scenarios on any scale, limited only by memory and the ability to determine the underlying topology and parameters.

Author Summary COVID-19 is a disease caused by the novel coronavirus SARS-CoV-2 that is both fatal and has a high transmission rate (R0), almost twice that of the 2017-2018 common influenza, presenting itself as a massive challenge to the world today. Existing mitigation strategies often are not efficient, and the mechanisms underlying complex infection patterns that distinguish themselves from simple curves remain unclear. Numerical modeling can identify pandemic mechanisms and inform policymakers how to improve mitigation strategies. One underexplored mechanism is social heterogeneity, specifically the contribution of vulnerable social subgroups, not accounted for by regional models. To investigate this, we developed a novel numerical model (dubbed SHEM) that examines the evolution of infection spread in a collection of diverse populations, connected by a network of links along which infection travels. We found that vulnerable subgroups that cannot implement mitigation strategies create infection hotspots which drive infection within and among urban areas, defeating mitigations. Furthermore, isolated vulnerable populations (which may hold a false sense of security in the real world) can create additional delayed infection spikes. This means effective mitigation of the COVID-19 pandemic requires close attention to vulnerable subgroups.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The work was supported by the Intramural Research Program of the National Institute on Aging, National Institute of Health.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This work is purely theoretical using models/simulations and does not use any real human subject data.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • Results were updated with additional simulations regarding a second wave in the integrated hotspot scenario. A new figure 4 was added. Old figure 4 regarding single cluster stochasticity was omitted because it did not include vulnerable subpopulations which are the focus of the study. Old figure 5 was moved to the supplementary materials (now figure S1). The paper text was revised accordingly.

Data Availability

All data is available in the manuscript and supplementary materials.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. This article is a US Government work. It is not subject to copyright under 17 USC 105 and is also made available for use under a CC0 license.
Back to top
PreviousNext
Posted September 18, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Social heterogeneity drives complex patterns of the COVID-19 pandemic: insights from a novel Stochastic Heterogeneous Epidemic Model (SHEM)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Social heterogeneity drives complex patterns of the COVID-19 pandemic: insights from a novel Stochastic Heterogeneous Epidemic Model (SHEM)
Alexander V. Maltsev, Michael D. Stern
medRxiv 2020.07.10.20150813; doi: https://doi.org/10.1101/2020.07.10.20150813
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Social heterogeneity drives complex patterns of the COVID-19 pandemic: insights from a novel Stochastic Heterogeneous Epidemic Model (SHEM)
Alexander V. Maltsev, Michael D. Stern
medRxiv 2020.07.10.20150813; doi: https://doi.org/10.1101/2020.07.10.20150813

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (238)
  • Allergy and Immunology (520)
  • Anesthesia (124)
  • Cardiovascular Medicine (1414)
  • Dentistry and Oral Medicine (217)
  • Dermatology (158)
  • Emergency Medicine (291)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (582)
  • Epidemiology (10273)
  • Forensic Medicine (6)
  • Gastroenterology (526)
  • Genetic and Genomic Medicine (2618)
  • Geriatric Medicine (254)
  • Health Economics (496)
  • Health Informatics (1728)
  • Health Policy (788)
  • Health Systems and Quality Improvement (671)
  • Hematology (266)
  • HIV/AIDS (564)
  • Infectious Diseases (except HIV/AIDS) (12074)
  • Intensive Care and Critical Care Medicine (647)
  • Medical Education (272)
  • Medical Ethics (83)
  • Nephrology (287)
  • Neurology (2450)
  • Nursing (144)
  • Nutrition (376)
  • Obstetrics and Gynecology (487)
  • Occupational and Environmental Health (566)
  • Oncology (1317)
  • Ophthalmology (398)
  • Orthopedics (145)
  • Otolaryngology (235)
  • Pain Medicine (168)
  • Palliative Medicine (51)
  • Pathology (342)
  • Pediatrics (776)
  • Pharmacology and Therapeutics (328)
  • Primary Care Research (295)
  • Psychiatry and Clinical Psychology (2392)
  • Public and Global Health (4991)
  • Radiology and Imaging (892)
  • Rehabilitation Medicine and Physical Therapy (522)
  • Respiratory Medicine (681)
  • Rheumatology (309)
  • Sexual and Reproductive Health (254)
  • Sports Medicine (244)
  • Surgery (296)
  • Toxicology (45)
  • Transplantation (140)
  • Urology (108)